We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Siemens and Varian in Global Collaboration to Develop Radiotherapy, Radiosurgery Advances

By HospiMedica International staff writers
Posted on 30 Apr 2012
Varian Medical Systems (Palo Alto, CA, USA) and Siemens Healthcare (Erlangen, Germany) recently signed a strategic global partnership to provide advanced diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery. More...


The collaboration encompasses the mutual marketing and representation of products for imaging and treatment in the global radiation oncology business. This partnership additionally comprises the development of software interfaces between Siemens and Varian treatment systems. The two companies will also explore opportunities for joint development of new products for image-guided radiotherapy and radiosurgery.

Under the agreement, Varian will represent Siemens diagnostic imaging products such as computed tomography (CT), positron emission tomography/computed tomography (PET/CT) or magnetic resonance imaging (MRI) to radiation oncology clinics around the world beginning immediately in most international markets and expanding to North America later in 2012.

Siemens Healthcare will correspondingly represent Varian equipment and software for radiotherapy and radiosurgery within its offerings to its healthcare customers. This will enable the companies to offer comprehensive solutions to support the entire clinical workflow from imaging to treatment. Siemens will continue to service and support its global installed base of about 2,000 medical linear accelerators. The agreement will give Siemens customers more choices for therapy equipment, including smooth transition and interface to Varian equipment, as aging accelerators are due for replacement.

Moreover, Varian and Siemens will develop interfaces that will enable connecting Varian’s Aria oncology information-system software with Siemens accelerators and imaging systems to provide clinics with more alternatives for improving workflow and streamlining their operations. The collaboration enables Varian and Siemens to co-develop and offer cancer treatment centers new imaging and treatment systems utilizing the capabilities and technology of both companies.

“This is an exciting development that will enable Varian to enhance and expand its clinical offerings for the benefit of cancer patients around the globe,” said Tim Guertin, president and CEO of Varian Medical Systems. “By developing strong software connectivity and new architecture linking Siemens and Varian systems, together we can give clinics important new options for imaging and treating patients. Another key objective of this partnership is to accelerate innovation and provide more efficient and effective solutions, particularly in emerging markets.”

“With this step under Siemens’ Healthcare Agenda 2013, we aim to strengthen our position as imaging partner of choice in radiation oncology,” said Walter Marzendorfer CEO of Siemens radiation oncology and computed tomography. “Through this collaboration, Siemens will continue to serve the global radiation oncology business and help improve the treatment of cancer patients around the globe with high-quality imaging and treatment solutions that utilize our core competency and engineering excellence in imaging.”

Siemens Healthcare is one of the world’s largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology, and hearing aids. Launched by Siemens Healthcare in November 2011, Agenda 2013 is a two-year global initiative to strengthen the healthcare sector’s innovative strength and competitiveness. Specific measures will be implemented in four fields of action: innovation, competitiveness, regional footprint, and people development.

Varian Medical Systems, Inc. is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices.

Related Links:

Varian Medical Systems
Siemens Healthcare




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
X-Ray System
Leonardo DR mini III
Pulmonary Ventilator
OXYMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.